D-dimer in african americans whole genome sequence analysis and relationship to cardiovascular disease risk in the Jackson Heart Study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 37, Issue 11, 2017, Pages 2220-2227

  Raffeld, Laura M ^a   Zakai, Neil A ^a,c   Duan, Qing ^a   Laurie, Cecelia ^a   Smith, Joshua D ^a   Irvin, Marguerite R ^e   Doyle, Margaret F ^a   Naik, Rakhi P ^f   Song, Ci ^g   Manichaikul, Ani W ^h   Liu, Yongmei ^i,j   Durda, Peter ^a   Rotter, Jerome I ^k   Jenny, Nancy S ^a   Rich, Stephen S ^h   Wilson, James G ^a   Johnson, Andrew D ^g   Correa, Adolfo ^l   Li, Yun ^a,b   Nickerson, Deborah A ^a   Rice, Kenneth ^a   Lange, Ethan M ^m   Cushman, Mary ^a,c   Lange, Leslie A ^m   Reiner, Alex P ^d   more..

^a Department of Genetics ^*  (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h UNIVERSITY OF VIRGINIA   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j HARBOR UCLA MEDICAL CENTER   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

Cardiovascular disease; Coagulation; Genetic epidemiology

Indexed keywords

D DIMER; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; HEMOGLOBIN VARIANT; THROMBOPLASTIN;

ADULT; AFRICAN AMERICAN; AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHROMOSOME 11; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EFFECT SIZE; FEMALE; GENE LOCUS; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; WHOLE GENOME SEQUENCING; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MORTALITY; MULTICENTER STUDY; PHENOTYPE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SICKLE CELL TRAIT; TIME FACTOR; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BIOMARKERS; CARDIOVASCULAR DISEASES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEMOGLOBINS, ABNORMAL; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PHENOTYPE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SICKLE CELL TRAIT; THROMBOPLASTIN; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 85032973093     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.117.310073     Document Type: Article

References (39)

1. Adam SS, Key NS, Greenberg CS. D-dimer antigen: Current concepts and future prospects. Blood. 2009;113:2878-2887. doi: 10.1182/blood-2008-06-165845.
2. Halaby R, Popma CJ, Cohen A, et al. D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis. 2015;39:55-59. doi: 10.1007/s11239-014-1101-6.
3. Zakai NA, Katz R, Jenny NS, Psaty BM, Reiner AP, Schwartz SM, Cushman M. Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: The Cardiovascular Health Study. J Thromb Haemost. 2007;5:1128-1135. doi: 10.1111/j.1538-7836.2007.02528.x.
4. Cushman M, Folsom AR, Wang L, Aleksic N, Rosamond WD, Tracy RP, Heckbert SR. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood. 2003;101:1243-1248. doi: 10.1182/blood-2002-05-1416.
5. Folsom AR, Alonso A, George KM, Roetker NS, Tang W, Cushman M. Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Res. 2015;136:781-785. doi: 10.1016/j.thromres.2015.08.013.
6. Folsom AR, Gottesman RF, Appiah D, Shahar E, Mosley TH. Plasma d-dimer and incident ischemic stroke and coronary heart disease: The Atherosclerosis Risk in Communities Study. Stroke. 2016;47:18-23. doi: 10.1161/STROKEAHA.115.011035.
7. Zakai NA, McClure LA, Judd SE, Kissela B, Howard G, Safford M, Cushman M. D-dimer and the Risk of Stroke and Coronary Heart Disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Thromb Haemost. 2017;117:618-624. doi: 10.1160/TH16-07-0519.
8. Di Castelnuovo A, de Curtis A, Costanzo S, Persichillo M, Olivieri M, Zito F, Donati MB, de Gaetano G, Iacoviello L; MOLI-SANI Project Investigators. Association of D-dimer levels with all-cause mortality in a healthy adult population: Findings from the MOLISANI study. Haematologica. 2013;98:1476-1480. doi: 10.3324/haematol.2012.083410.
9. Folsom AR, Delaney JA, Lutsey PL, Zakai NA, Jenny NS, Polak JF, Cushman M; Multiethnic Study of Atherosclerosis Investigators. Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality. Am J Hematol. 2009;84:349-353. doi: 10.1002/ajh.21429.
10. Oneal WT, Soliman EZ, Howard G, Howard VJ, Safford MM, Cushman M, Zakai NA. Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study. Atherosclerosis. 2015;243:192-197. doi: 10.1016/j.atherosclerosis.2015.09.009.
11. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD. Fibrin D-dimer and coronary heart disease: Prospective study and meta-analysis. Circulation. 2001;103:2323-2327.
12. Willeit P, Thompson A, Aspelund T, Rumley A, Eiriksdottir G, Lowe G, Gudnason V, Di Angelantonio E. Hemostatic factors and risk of coronary heart disease in general populations: New prospective study and updated meta-analyses. PLoS One. 2013;8:e55175. doi: 10.1371/journal. pone.0055175.
13. Kleinegris MC, ten Cate H, ten Cate-Hoek AJ. D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease. A systematic review. Thromb Haemost. 2013;110:233-243. doi: 10.1160/TH13-01-0032.
14. Ay C, Dunkler D, Pirker R, Thaler J, Quehenberger P, Wagner O, Zielinski C, Pabinger I. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97:1158-1164. doi: 10.3324/haematol.2011.054718.
15. Lutsey PL, Cushman M, Steffen LM, Green D, Barr RG, Herrington D, Ouyang P, Folsom AR. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: The MESA study. J Thromb Haemost. 2006;4:2629-2635. doi: 10.1111/j.1538-7836.2006.02237.x.
16. Weng LC, Tang W, Rich SS, Smith NL, Redline S, Odonnell CJ, Basu S, Reiner AP, Delaney JA, Tracy RP, Palmer CD, Young T, Yang Q, Folsom AR, Cushman M. A genetic association study of D-dimer levels with 50K SNPs from a candidate gene chip in four ethnic groups. Thromb Res. 2014;134:462-467. doi: 10.1016/j.thromres.2014.05.018.
17. Khaleghi M, Saleem U, McBane RD, Mosley TH Jr, Kullo IJ. African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension. J Thromb Haemost. 2009;7:34-40. doi: 10.1111/j.1538-7836.2008.03215.x.
18. Smith NL, Huffman JE, Strachan DP, et al. Genetic predictors of fibrin D-dimer levels in healthy adults. Circulation. 2011;123:1864-1872. doi: 10.1161/CIRCULATIONAHA.110.009480.
19. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: A clinical perspective. Ann Intern Med. 1997;127:895-903.
20. Lim ET, Würtz P, Havulinna AS, et al; Sequencing Initiative Suomi (SISu) Project. Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet. 2014;10:e1004494. doi: 10.1371/journal.pgen.1004494.
21. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, Boehnke M, Abecasis GR, Willer CJ. LocusZoom: Regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336-2337. doi: 10.1093/bioinformatics/btq419.
22. Williams FM, Carter AM, Hysi PG, et al; EuroCLOT Investigators; Wellcome Trust Case Control Consortium 2; MOnica Risk, Genetics, Archiving and Monograph; MetaStroke; International Stroke Genetics Consortium. Ischemic stroke is associated with the ABO locus: The EuroCLOT study. Ann Neurol. 2013;73:16-31. doi: 10.1002/ana.23838.
23. Ariëns RA, de Lange M, Snieder H, Boothby M, Spector TD, Grant PJ. Activation markers of coagulation and fibrinolysis in twins: Heritability of the prethrombotic state. Lancet. 2002;359:667-671. doi: 10.1016/S0140-6736(02)07813-3.
24. Diego VP, Almasy L, Rainwater DL, Mahaney MC, Comuzzie AG, Cole SA, Tracy RP, Stern MP, Maccluer JW, Blangero J. A quantitative trait locus on chromosome 5p influences d-dimer levels in the san antonio family heart study. Int J Vasc Med. 2010;2010:490241. doi: 10.1155/2010/490241.
25. Bladbjerg EM, de Maat MP, Christensen K, Bathum L, Jespersen J, Hjelmborg J. Genetic influence on thrombotic risk markers in the elderly-a Danish twin study. J Thromb Haemost. 2006;4:599-607. doi: 10.1111/j.1538-7836.2005.01778.x.
26. Souto JC, Almasy L, Borrell M, Garí M, Martínez E, Mateo J, Stone WH, Blangero J, Fontcuberta J. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation. 2000;101:1546-1551.
27. Lange LA, Reiner AP, Carty CL, Jenny NS, Cushman M, Lange EM. Common genetic variants associated with plasma fibrin D-dimer concentration in older European-and African-American adults. J Thromb Haemost. 2008;6:654-659. doi: 10.1111/j.1538-7836.2008.02906.x.
28. Lutsey PL, Wassel CL, Cushman M, Sale MM, Divers J, Folsom AR. Genetic admixture is associated with plasma hemostatic factor levels in self-identified African Americans and Hispanics: The Multi-Ethnic Study of Atherosclerosis. J Thromb Haemost. 2012;10:543-549. doi: 10.1111/j.1538-7836.2012.04663.x.
29. Naik RP, Wilson JG, Ekunwe L, Mwasongwe S, Duan Q, Li Y, Correa A, Reiner AP. Elevated D-dimer levels in African Americans with sickle cell trait. Blood. 2016;127:2261-2263. doi: 10.1182/blood-2016-01-694422.
30. Westerman MP, Green D, Gilman-Sachs A, Beaman K, Freels S, Boggio L, Allen S, Schlegel R, Williamson P. Coagulation changes in individuals with sickle cell trait. Am J Hematol. 2002;69:89-94.
31. Amin C, Adam S, Mooberry MJ, Kutlar A, Kutlar F, Esserman D, Brittain JE, Ataga KI, Chang JY, Wolberg AS, Key NS. Coagulation activation in sickle cell trait: An exploratory study. Br J Haematol. 2015;171:638-646. doi: 10.1111/bjh.13641.
32. Lawrie AS, Pizzey A, Trompeter S, Meiselman H, Mohandas N, Dumanski JP, Westerman MP. Procoagulant activity in patients with sickle cell trait. Blood Coagul Fibrinolysis. 2012;23:268-270. doi: 10.1097/MBC.0b013e32835187f8.
33. Hamer JD, Malone PC, Silver IA. The PO2 in venous valve pockets: Its possible bearing on thrombogenesis. Br J Surg. 1981;68:166-170.
34. Noguchi CT, Torchia DA, Schechter AN. Polymerization of hemoglobin in sickle trait erythrocytes and lysates. J Biol Chem. 1981;256: 4168-4171.
35. Whelihan MF, Lim MY, Mooberry MJ, Piegore MG, Ilich A, Wogu A, Cai J, Monroe DM, Ataga KI, Mann KG, Key NS. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease. J Thromb Haemost. 2016;14:1941-1952. doi: 10.1111/jth.13416.
36. Martin JS, Xu Z, Reiner AP, Mohlke KL, Sullivan P, Ren B, Hu M, Li Y. Hugin: Hi-c unifying genomic interrogator [published online ahead of print June 5, 2017]. Bioinformatics. doi: 10.1093/bioinformatics/btx359. https://doi.org/10.1093/bioinformatics/btx359.
37. Ward LD, Kellis M. HaploReg: A resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(database issue):D930-D934. doi: 10.1093/nar/gkr917.
38. Lockwood CJ, Murk W, Kayisli UA, Buchwalder LF, Huang ST, Funai EF, Krikun G, Schatz F. Progestin and thrombin regulate tissue factor expression in human term decidual cells. J Clin Endocrinol Metab. 2009;94:2164-2170. doi: 10.1210/jc.2009-0065.
39. Smith NL, Heit JA, Tang W, Teichert M, Chasman Di, Morange PE; Venous Thrombosis Genetic Replication Consortium. Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: Metaanalysis of eight studies. J Thromb Haemost. 2012;10:719-722. doi: 10.1111/j.1538-7836.2012.04665.x.